GPX1 Gene Test (Glutathione Peroxidase 1)

• Identify whether you carry GPX1 variants that may reduce enzyme efficiency and increase reliance on selenium, glutathione, and other antioxidant systems to keep hydrogen peroxide and lipid peroxides in a healthy range.
• Help explain a tendency toward higher oxidative stress markers, exercise-related muscle soreness, or slower recovery even when training and sleep appear well structured.
• Inform personalised antioxidant, selenium, and glutathione support strategies, especially in the context of cardiometabolic, thyroid, or neurodegenerative risk where oxidative stress plays a role.
• Provide genetic context when using medications or therapies that increase oxidative load, supporting tailored monitoring and lifestyle support in partnership with your clinician.
• Clarify your baseline redox defence capacity alongside other biomarkers, so resilience and longevity plans can be built on both genetics and real-time blood data over the long term.

Glutathione peroxidase 1 (GPX1) is a key selenium-dependent antioxidant enzyme that reduces hydrogen peroxide and organic hydroperoxides by using glutathione as an electron donor. The GPX1 gene provides the instructions for building this cytosolic enzyme, which is widely expressed across tissues and helps maintain intracellular redox balance.

Common GPX1 polymorphisms, such as the Pro198Leu (often written as rs1050450), can alter enzyme activity, localisation, or responsiveness to selenium status. These variants do not usually cause overt deficiency, but they can nudge how efficiently your cells clear reactive oxygen species, particularly when selenium intake or glutathione availability is marginal.

GPX1 sits at a crucial point in the antioxidant network by using reduced glutathione to convert hydrogen peroxide and lipid hydroperoxides into water and corresponding alcohols, while oxidising glutathione to its disulfide form. This reaction helps protect membranes, mitochondrial structures, and DNA from peroxidative damage, especially under metabolic stress.

Because GPX1 is selenium dependent, its activity reflects both your genetic pattern and your micronutrient environment. When GPX1 activity is reduced due to variants, low selenium, or depleted glutathione, peroxides can accumulate and contribute to oxidative damage, which in turn can influence vascular function, insulin signalling, thyroid hormone handling, and cellular ageing.

GPX1 contributes to three interconnected systems: antioxidant and glutathione defence, metabolic and cardiovascular health, and mitochondrial and neurological function. By controlling peroxides, GPX1 helps stabilise membranes, lipoproteins, and mitochondrial respiratory complexes that underpin energy production and cellular resilience.

Research has explored links between GPX1 variants and risk of conditions such as cardiovascular disease, type 2 diabetes, certain cancers, and neurodegenerative disorders, often alongside other genes and lifestyle factors. The real-world impact of common GPX1 polymorphisms is modest and context dependent, with risk increasing mainly when diet quality, selenium intake, and metabolic health are not optimised.

It is easy to assume that GPX1 testing and oxidative stress blood markers tell you the same story, but they capture different layers of your biology. GPX1 genotyping looks at inherited capacity for glutathione peroxidase activity, whereas markers such as high-sensitivity CRP, oxidised LDL, or specific oxidative damage assays reflect real-time inflammatory and redox load under your current lifestyle.

This distinction matters because you can carry a GPX1 variant associated with lower enzyme activity and still maintain balanced oxidative stress if selenium status, glutathione supply, and metabolic health are well supported. Conversely, oxidative stress markers can be elevated without notable GPX1 variants due to factors such as chronic inflammation, hyperglycaemia, or environmental exposures, which often respond well to targeted behaviour change and clinical support.

The influence of GPX1 variants is shaped far more by environment and habits than by the gene alone, which means you have meaningful room to change the trajectory. Several modifiable factors can either buffer genetic effects or amplify them.

• Selenium status: Adequate dietary selenium intake is central to GPX1 synthesis and activity. Low selenium intake, restrictive diets, or malabsorption can make GPX1 variants more clinically relevant, while optimal selenium helps unlock the full potential of your genetic capacity.
• Glutathione availability: GPX1 relies on a robust glutathione pool, which depends on amino acid supply, methylation and transsulfuration pathways, and overall metabolic health. Diets poor in protein and sulfur-containing amino acids, or chronic oxidative load, can deplete glutathione and magnify GPX1-related vulnerabilities.
• Metabolic and cardiovascular health: Insulin resistance, central adiposity, and dyslipidaemia independently raise oxidative stress and lipid peroxidation. When these are present, GPX1 variants that reduce peroxide clearance can become more relevant for vascular and mitochondrial health.
• Co-occurring antioxidant genes: GPX1 acts in concert with CAT, SOD2, GSTP1, and regulators such as NFE2L2, so the combined genetic background shapes overall antioxidant capacity. Interpreting GPX1 within a broader DNA and biomarker panel gives a more realistic picture than focusing on a single gene.
• Lifestyle and environmental exposures: Smoking, high alcohol intake, pollution, ultraviolet exposure, and certain medications increase oxidative load and can make GPX1-related differences more visible. Regular movement, good sleep, and stress management help rebalance redox status over time.
• Training load and recovery: Endurance and high-intensity training increase reactive oxygen species generation in muscle and mitochondria. For someone with less efficient GPX1 activity, smart programming, recovery strategies, and nutrient support can help convert this stress into adaptation rather than chronic fatigue.

Yes, and that is very common. Most people with GPX1 variants never experience direct, recognisable symptoms and usually discover their status through preventative DNA or methylation panels.

Many experiences that people attribute to "oxidative stress," such as tiredness, brain fog, or muscle soreness, are non-specific and can arise from sleep disruption, low mood, under-recovery, micronutrient gaps, or other health conditions. Severe congenital glutathione peroxidase deficiencies are rare and usually identified in specialist settings with distinctive clinical features, and they are distinct from the common polymorphisms reported on standard DNA reports.

Common GPX1 genotypes mainly differ in how they influence enzyme activity and responsiveness to selenium, especially under oxidative pressure, and how strongly they nudge redox balance when combined with lifestyle factors. Understanding your pattern can help tailor selenium, glutathione, and training strategies instead of labelling you as having a "good" or "bad" genotype.

• Reference or higher-activity patterns: Genotypes associated with preserved GPX1 activity provide relatively robust peroxide clearance when selenium and glutathione status are adequate. In this group, overall redox balance is driven more by diet, metabolic health, and exposures than by GPX1 itself.
• Variants such as Pro198Leu: Some GPX1 variants are linked with lower enzyme activity or altered localisation, which can modestly reduce peroxide handling capacity, particularly when selenium intake is marginal. In the presence of metabolic dysfunction or chronic inflammation, this can shift risk toward oxidative-stress-related complications, making proactive lifestyle and nutrient strategies more important.
• Combined patterns with other antioxidant genes: Individuals who carry GPX1 variants alongside changes in SOD2, CAT, or GSTP1 may experience a more pronounced reduction in antioxidant capacity. Here, coordinated support across diet, movement, sleep, and targeted supplementation can produce meaningful improvements in biomarkers and day-to-day resilience.
• Rare, more disruptive changes: Rare GPX1 variants with greater functional impact typically appear in specialist contexts and are not the focus of standard preventative health panels, but the same principles of supporting selenium status and glutathione still apply.

For DNA-based GPX1 testing, preparation is straightforward because your genotype does not change from day to day with meals, exercise, or sleep. The priority is selecting a panel that places GPX1 within a broader oxidative stress, methylation, and metabolic framework so the insights translate into clear next steps.

Standalone GPX1 genotyping using blood or saliva does not require fasting, since it analyses stable DNA rather than fluctuating blood levels. If GPX1 is bundled with markers such as hs-CRP, glucose, lipids, or oxidative stress assays, your clinician or testing instructions may recommend specific fasting windows or standardised collection conditions so you can track changes reliably over time.

A GPX1 test is most valuable when the result will influence how you personalise antioxidant strategies, selenium intake, metabolic prevention, or training and recovery decisions as part of a wider redox and longevity plan. It is less useful when run in isolation without access to oxidative, metabolic, and inflammatory biomarkers.

• Cardiometabolic or thyroid concerns: If you have a personal or family history of type 2 diabetes, cardiovascular disease, or thyroid issues, GPX1 testing alongside related markers can add context to how proactive you may want to be with selenium, glutathione support, and lifestyle changes.
• High training loads or demanding lifestyles: For people regularly pushing performance, whether in sport or cognitively demanding roles, GPX1 status can help fine-tune recovery strategies and antioxidant support so training stress builds resilience rather than background fatigue.
• Chronic inflammatory or autoimmune conditions: If you are living with ongoing inflammation or autoimmune disease, GPX1 genotyping combined with serial biomarkers can guide a more personalised approach to diet, supplementation, and environmental exposures in partnership with your care team.
• Building a redox and longevity roadmap: For those investing in preventative testing, GPX1 genotyping alongside other oxidative genes, blood markers, and microbiome insights provides a durable piece of information that can be revisited at key life stages and medication changes.